Related Experiment Video
Updated: Sep 19, 2025

06:24
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
1.3K
Modulating Proliferation, Migration and Differentiation of Mesenchymal Stem Cells Using Interleukins
Sankaranarayanan Srinivasan1, Nalinkanth V Ghone2
1Department of Biotechnology, Indian Institute of Technology Madras, Chennai, 600 036, Tamil Nadu, India.
Current Stem Cell Research & Therapy
|June 17, 2025
Summary
Interleukins significantly influence Mesenchymal Stem Cells (MSCs) functions, impacting their therapeutic potential. Understanding these cytokine interactions is key to harnessing MSCs for regenerative medicine and mitigating risks.
Area of Science:
- Stem Cell Biology
- Immunology
- Regenerative Medicine
Background:
- Mesenchymal Stem Cells (MSCs) possess multipotency, regenerative potential, and immunomodulatory properties, making them promising for tissue engineering and therapies.
- MSCs migrate to injured tissues and interact with cytokines, which modulate their activity for regeneration.
- Interleukins are key cytokines in the microenvironment of injured tissues, influencing MSC behavior.
Purpose of the Study:
- To review the influence of interleukins on Mesenchymal Stem Cells (MSCs).
- To discuss the signaling pathways and biological effects of interleukins on MSCs.
- To provide insights for enhancing MSC therapeutic potential and reducing risks.
Main Methods:
- Literature review focusing on the interactions between interleukins and MSCs.
- Analysis of signaling pathways involved in interleukin-mediated MSC modulation.
- Examination of the effects of interleukins on MSC differentiation, proliferation, migration, and adhesion.
Main Results:
- Interleukins modulate MSCs through autocrine and paracrine signaling.
- Specific interleukins influence MSC activation, differentiation, proliferation, maturation, migration, and adhesion.
- Understanding these interactions is crucial for optimizing MSC-based therapies.
Conclusions:
- Interleukins play a critical role in regulating MSC functions.
- Manipulating interleukin signaling can enhance the therapeutic efficacy of MSCs.
- Further research into interleukin-MSC interactions may reduce adverse effects like immune responses and tumor formation.
Keywords:
Mesenchymal stem cellsdifferentiationinterleukinsmigrationmodulationproliferation.receptorssignaling pathwaysMore Related Videos
Related Concept Videos
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Stem Cell Niche
5.3K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.3K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

